Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Biliary Duct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07825935
What this trial is testing

Individualized Drainage Strategy Based on Risk Stratification in Children Undergoing Surgery for Choledochal Cyst: A Prospective Randomized Controlled Trial

Who this might be right for
Children Following Robot-assisted Roux-en-Y Hepaticojejunostomy for Choledochal CystsCholedochal Cyst
Xueqiang Yan 80
Not applicableEnded earlyNCT03852836
What this trial is testing

Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images

Who this might be right for
GallstoneCholangitisCholangiocarcinoma+2 more
IHU Strasbourg 53
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT02284802
What this trial is testing

Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy

Who this might be right for
Barrett EsophagusGastric Antrectomy PartialBiliary Duct Stricture+4 more
Fauze Maluf Filho 87
Testing effectiveness (Phase 2)Study completedNCT01954745
What this trial is testing

Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Who this might be right for
Bile Duct CancerIntrahepatic CholangiocarcinomaCholangiocarcinoma of the Extrahepatic Bile Duct
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT02392637
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers

Who this might be right for
Stage III Intrahepatic Cholangiocarcinoma AJCC v7Stage IIIA Gallbladder Cancer AJCC v7Stage IIIB Gallbladder Cancer AJCC v7+6 more
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT03003065
What this trial is testing

Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers

Who this might be right for
CholangiocarcinomaTumorKlatskin Tumor
Chinese University of Hong Kong 10
Early research (Phase 1)Study completedNCT00955149
What this trial is testing

Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Primary Sclerosing CholangitisTrisomy 7Cholangiocarcinoma+1 more
Mayo Clinic 6
Testing effectiveness (Phase 2)Study completedNCT00919061
What this trial is testing

Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Not applicableStudy completedNCT06223061
What this trial is testing

Global Evaluation of Cholecystectomy Knowledge and Outcomes

Who this might be right for
GallstoneGallbladder CancerBile Duct Injury
University of Edinburgh 53,708
Large-scale testing (Phase 3)Study completedNCT03093870
What this trial is testing

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
ASLAN Pharmaceuticals 151
Not applicableStudy completedNCT04801719
What this trial is testing

Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis

Who this might be right for
Radiofrequency AblationBiliary Tract CancerStent Complication+1 more
Brno University Hospital 76
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00262769
What this trial is testing

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 324
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Not applicableLooking for participantsNCT03637569
What this trial is testing

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

Who this might be right for
Pancreas CancerCholangiocarcinomaGallbladder Cancer
Samsung Medical Center 1,000
Not applicableStudy completedNCT00779688
What this trial is testing

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

Who this might be right for
Pancreatic CancerBile Duct Cancer
Mauna Kea Technologies 130
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)WithdrawnNCT02856568
What this trial is testing

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Non-Resectable CholangiocarcinomaRecurrent CholangiocarcinomaStage III Extrahepatic Bile Duct Cancer+10 more
Mayo Clinic
Next Page